Cookies on the
LGC website
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on the LGC website. However, if you would like to, you can change your cookie settings at anytime.
Question markFind out more

LGC and Covaris partner for innovative DNA-extraction solution

24 Jun 2013
LGC and Covaris, Inc – the global leader in the field of sample preparation using Adapted focused Acoustics (AFA) - are partnering to develop an innovative solution for the high-throughput extraction of Nucleic Acids from Formalin-Fixed, Paraffin Embedded (FFPE) tissue samples.

With more than 20 years experience in nucleic acid extraction and a strong portfolio of patented products, the nucleic acid purification solutions from LGC include both the sbeadex® magnetic microparticles and Kleargene spin plates for automated extraction of high quality DNA.

Giulio Cerroni, LGC Genomics Managing Director commented, “We are delighted to be working with Covaris to develop this application together.  Linking our sbeadex and Kleargene technologies with the Covaris technology will provide our customers in both pathology and research laboratories with a complete solution that will enable them to process FFPE samples significantly more efficiently, whilst also providing high yields, reproducibly.”

Covaris CEO, Jim Laugharn, added, “This collaboration will provide a solution to overcome traditional short-comings and barriers.  We will improve the extraction workflow and provide higher quality samples and higher quality results in a high throughput environment”. 

Integrating LGC’s DNA purification techniques with Covaris’ FFPE extraction workflow will offer customers a complete high-throughput solution, from FFPE tissue to high quality DNA, with the ability to process thousands of FFPE samples per week.

For more on FFPE Nucleic Acid extraction please click here.